CYP3A4 and MDR1 alleles in a Portuguese population

I Cavaco, JP Gil, E Gil-Berglund, V Ribeiro - 2003 - degruyter.com
Polymorphisms in cytochrome P450 CYP3A4 and multidrug resistance (MDR) 1 genes
coding for the important drugmetabolising CYP3A4 and the ATP-binding cassette (ABC) …

[引用][C] CYP3A4, CYP3A5 and MDR‐1 variant alleles in the Dutch Caucasian population

R Van Schaik, M Van der Werf… - Clinical …, 2003 - Wiley Online Library
CYP3A4, CYP3A5 and MDRâ•’1 Variant Alleles in The Dutch Caucasian Population Page 1
CLINICAL PHARMACOLOGY & TH ERAPEUTICS P42 American Society Cbr Clinical …

Differences in CYP3A5* 3 genotype distribution and combinations with other polymorphisms between Spaniards and other Caucasian populations

G Gervasini, S Vizcaino, C Gasiba… - Therapeutic drug …, 2005 - journals.lww.com
The goal of this study was to detect genotypic differences between Spaniards and other
related populations regarding CYP3A4* 1B, CYP3A5* 3, and ABCB1 (MDR1) C3435T …

CYP3A5* 3 and MDR-1 C3435T single nucleotide polymorphisms in six Chinese ethnic groups

Y Lai, J Zhang, YX Wang, XD Wang… - Die Pharmazie-An …, 2011 - ingentaconnect.com
The prevalent CYP3A5* 3 and the functional multi-drug resistance gene (MDR1) C3435T
show marked interethnic variation among Orientals, Caucasians and Africans. This study …

Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups

D Li, GL Zhang, YQ Lou, Q Li, X Wang… - Journal of clinical …, 2007 - Wiley Online Library
Background and objective: The drug transporter MDR1 and the drug metabolizing enzyme
CYP3A are the two major biological factors determining the pharmacokinetics of many …

Design of allele specific PCR for rapid detection of CYP3A5 (A6986G) and Mdr-1 (C3435T) polymorphisms

TF Ashavaid, HS Raje, BV Shah, SA Shah - Indian Journal of Clinical …, 2011 - Springer
Single nucleotide polymorphisms in CYP3A5 (A6986G) and MDR-1 (C3435T) genes have
been shown to be associated with the pharmacokinetics of tacrolimus in case of renal …

Characterization of pharmacogenetically relevant CYP2D6 and ABCB1 gene polymorphisms in a Portuguese population sample

C Correia, P Santos, AM Coutinho… - Cell Biochemistry and …, 2009 - Wiley Online Library
Differences in metabolism of drugs can lead to severe toxicity or therapeutic failure. In
addition to cytochrome P450 2D6, which plays a critical role in drug metabolism, ABCB1 …

CYP3A activity measured by the midazolam test is not related to 3435 C> T polymorphism in the multiple drug resistance transporter gene

CB Eap, J Fellay, T Buclin, G Bleiber… - Pharmacogenetics …, 2004 - journals.lww.com
A recent study with 69 Japanese liver transplants treated with tacrolimus found that the
MDR1 3435 C> T polymorphism, but not the MDR1 2677 G> T polymorphism, was …

Genetic polymorphism of cytochrome P450s and P‐glycoprotein in the Finnish population

J Hilli, A Rane, S Lundgren… - Fundamental & …, 2007 - Wiley Online Library
The objective of this study was to investigate the genetic polymorphism of selected
cytochrome P450 (CYP) enzymes and ABCB1 (encoding P‐glycoprotein) of central …

MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotype

J Lamba, S Strom, R Venkataramanan… - Clinical …, 2006 - Wiley Online Library
Objectives Variant cytochrome P450 (CYP) 3A4 alleles cannot explain human variation in
CYP3A4 expression. This study investigated whether common single‐nucleotide …